Demand for Drug Screening in USA

Future Market Insights

Key Insight

The demand for drug screening in USA is projected to grow from USD 3.6 billion in 2025 to USD 15.3 billion by 2035, at a CAGR of 15.7%. Urine Samples will dominate with a 35.0% market share, while drug screening will lead the product and service segment with a 28.0% share.

December 12, 2025

Anurag Sharma

250 Pages

Cite this Report

Demand for Drug Screening in USA

https://www.futuremarketinsights.com/reports/united-states-drug-screening-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Bio-Rad Laboratories
BioMerieux SA
Express Diagnostics Int’l
Hoffmann-La Roche Ltd
Laboratory Corporation of America Holdings

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Demand for Drug Screening in USA

Key Players

Similar Industry Reports